Deere & Company (NYSE: DE) — The Best Franchise in Farming, Priced for the Recovery It Keeps Postponing

Date: 2026-06-12 Price at writing: ~$568.64 (2026-06-11 close) · Market cap: ~$155B · Shares out: ~270M · 52-wk range: $433–$674 Sector: Industrials — Farm & Heavy Construction Machinery Fiscal year: late October/early November · CIK: 0000315189

⚡ Claude’s Take

This block is the author’s own independent opinion and general information only — not investment advice. The analysis that follows takes no position and carries no price target; this opening block is the single place a view is expressed.

Verdict: HOLD — a genuinely best-in-class franchise at a full-but-not-absurd price. Accumulate on weakness, do not chase here. Directional framing: Deere is the highest-quality agricultural-equipment business in the world, two years into a deliberately-managed down-cycle, trading at ~31x trough earnings but only ~13–14x management’s claimed mid-cycle earnings (~$40–45). The whole call reduces to which of those two anchors you believe. On a blended view I find DE fair-to-fully-valued in the ~$470–560 zone (roughly 11–13x a defensible ~$42 mid-cycle EPS), genuinely attractive below ~$450 (where it traded at the 2025 lows, ~10–11x mid-cycle), and demanding real faith in the 2027+ recovery above ~$600. At ~$569 — the 89th percentile of its own ten-year valuation history on a composite basis, 96th on P/S — you are paying a quality-leader premium (a ~80% forward-P/E premium to ag peers AGCO/CNH/Kubota) for a business whose own management has just pushed its two headline 2030 ambitions — 20% mid-cycle margins and a 10%-of-revenue recurring-software mix — past 2030. The market is correctly looking through the trough; it is simply not leaving you much margin of safety for the look-through being early.

The mispricing, in one breath: This is not a CAT-style “cyclical at peak earnings AND peak multiple” double-jeopardy setup — it is closer to the inverse. Earnings are at a trough (FY26 is guided to be a second trough, net income $4.5–5.0B, possibly below FY25’s $5.0B), so the optically-scary 31x P/E is a denominator illusion. The bull is right that you normalize. The subtlety the bull underweights: (1) DE sits at the top of its own valuation range despite trough earnings — the market has already normalized, so there is no “cheap cyclical” discount to harvest; (2) management’s mid-cycle $40–45 EPS requires the 20% structural margin that tariffs and a soft ag market have just deferred; and (3) the parts-and-service aftermarket annuity that is the financial core of the moat is under direct legal attack (FTC + five state AGs + an antitrust MDL on right-to-repair). The framing here is quality-compounder-at-a-fair-price / patient-accumulation, not a contrarian bargain and not a short. Deere’s production discipline (underproducing retail demand ~10%, draining used inventory to multi-year lows) is genuine, best-in-class cycle management that sets up real operating leverage when the replacement wave finally turns — which is exactly why it is not a short.

Conviction: medium. The single piece of evidence that would flip me decisively bullish: confirmation the ag cycle has bottomed with the large-ag replacement wave inflecting up (220hp+ tractor field inventory at a 17-year low + an aging fleet is the fuel) and the price re-set toward ~$470 or below, restoring a margin of safety. The single piece that would flip me bearish: a material adverse right-to-repair outcome that forces Deere to open its repair tooling/parts to independents, structurally eroding the high-margin aftermarket annuity — or evidence the mid-cycle margin target keeps slipping (a third deferral) while the multiple stays at 89th-percentile. Tag: “The best farm in the county — but you’re paying for next year’s harvest before this year’s rain.”

1. Executive Summary

Deere & Company is the world’s preeminent agricultural-equipment manufacturer — a 188-year-old franchise that dominates North American large agriculture with roughly half of the high-horsepower tractor market and ~60% of the combine market, sells through a dense network of independent green-and-yellow dealers, and surrounds its installed base with a captive parts-and-service annuity and a captive finance arm (John Deere Financial). By every structural test that matters — market-share stability over decades, through-cycle returns on capital far above cost, brand pricing power, and an integrated precision-agriculture technology stack — it is one of the highest-quality businesses in global capital goods. The question, as with most great businesses, is price and timing, not quality.

Deere is two years into a severe, classic agricultural down-cycle. Net income attributable to Deere fell from a $10.17B peak in FY2023 to $7.10B in FY2024 to $5.03B in FY2025 — a ~50% peak-to-trough collapse — as North American large-ag industry demand fell ~30% in FY2025 alone, driven by a slump in net farm income, lower corn and soybean prices, and a glut of used high-horsepower equipment. Diluted EPS fell from $34.63 (FY23) to $18.50 (FY25). And the bottom is not yet behind: management guides FY2026 net income to $4.5–5.0B, i.e. a second consecutive trough year, with large-ag (Production & Precision Ag) sales still declining 5–10% even as Small Ag & Turf (+~15%) and Construction & Forestry (+~20%) recover. Management’s stated base case is that “2026 will represent the bottom of the ag cycle,” with recovery beginning in 2027.

The central analytical tension is the gap between trough and normalized earnings. At ~$569, DE trades at ~31x trailing EPS — which looks expensive until you recognize the denominator is depressed. On management’s own normalized framework — mid-cycle EPS of ~$40–45, a next-cycle bottom of ~$20–25, and a top of ~$55–60 — the stock is only ~13–14x mid-cycle. The bull case is that you should pay a premium for the best franchise in a structurally-improved cyclical at the bottom of its cycle; the bear case is that (a) DE sits at the top of its own ten-year valuation range despite trough earnings (89th-percentile composite, 96th-percentile on price-to-sales), so the recovery is already priced; (b) the mid-cycle margin target (20% structural operating return on sales) has been pushed past 2030 by tariffs; © the celebrated recurring-software revenue ramp has also been deferred past 2030 by management itself; and (d) the aftermarket-parts annuity faces a genuine right-to-repair legal assault.

The capital-allocation record is strong but imperfect: a 25-year history of returning the great majority of equipment-operations free cash flow, a dividend grown ~16% annually to $6.48, and a build-not-buy discipline (goodwill is only ~$4.2B, ~4% of assets) — offset by a pro-cyclical buyback that spent the most at the FY23 peak (~$7.2B) and the least in the FY25 trough (~$1.1B). Insider conviction is absent: exactly one open-market purchase across the entire executive/director group in five years.

This memo takes no position and sets no price target. It lays out, with evidence, what the current price requires the buyer to believe, where the moat is durable and where it is contested, and the specific facts that would confirm or break each side. The recurring theme: Deere is an exceptional, structurally-improved cyclical franchise trading near the top of its own valuation history at the bottom of its earnings cycle — a configuration that rewards patience over urgency.

2. Business Overview

What the company does. Deere designs, manufactures, distributes, and finances agricultural, turf, construction, and forestry equipment, and the technology, parts, and services that surround them. Founded in 1837 in a Grand Detour, Illinois blacksmith shop, headquartered in Moline, Illinois, with ~73,100 employees, it is the global #1 in agricultural machinery. FY2025 (a 53-week year ended November 2, 2025) worldwide net sales and revenues were $45.68B, down ~12% from $51.72B; equipment-operations net sales were $38.92B, down ~13% from $44.76B; net income attributable to Deere was $5.03B (12.9% return on net sales), with diluted EPS of $18.50 [FY2025 10-K, filed 2025-12-18].

Segments. Deere reports through four segments — three equipment segments plus a captive finance arm:

[Source: FY2025 10-K segment data. PPA operating profit fell -62% peak-to-trough (FY23 $7.0B → FY25 $2.7B); C&F margin collapsed from 18.2% to 9.0%.]

Revenue mix and geography. FY2025 net sales split roughly 52% United States ($23.97B), with Western Europe $6.55B, Latin America $5.61B (Brazil-heavy), and Canada $3.74B. Critically, ~80% of complete goods sold to US customers are built in the US — a meaningful relative advantage in a tariff-disrupted environment, though the supply chain remains import-exposed.

How it makes money — and the recurring ballast. Three ways, in declining cyclicality: (1) selling new equipment (cyclical, the bulk of revenue); (2) selling parts, service, and increasingly precision-ag technology and subscriptions into the installed base (recurring, higher-margin, counter-cyclical); and (3) financing the purchase of all of it through John Deere Financial (a spread business that earns more profit in the downturn — FS operating profit actually rose from $0.80B in FY23 to $1.11B in FY25 on lower credit costs). The aftermarket-parts annuity is the model’s counter-cyclical buffer: even when a farmer defers a new combine, he keeps running, repairing, and parts-stocking the existing fleet — and historically buys those parts through the Deere dealer. Deere does not separately disclose aftermarket-parts revenue, but it is the financial heart of the moat and the direct target of the right-to-repair litigation.

The precision-ag overlay. Layered on the iron is the “Smart Industrial” strategy (launched 2020): the John Deere Operations Center now manages 500M+ engaged acres, with See & Spray (targeted herbicide application, 50–60% chemical savings), autonomy, ExactShot, and JDLink/Starlink connectivity. This is real and deepening — but its revenue monetization is immature and has been deferred.

Verdict. A diversified, global, best-in-class equipment franchise with a genuine recurring-revenue and captive-finance ballast, anchored by a dominant North American large-ag position. The business is well-understood, cash-generative, and durable, but its earnings are deeply cyclical — ~71% of equipment sales (PPA + SAT) are tied to the agricultural capital-spending cycle, which is currently at or near its trough.

3. Industry Dynamics

Deere competes in two structurally distinct industries — agricultural equipment (a concentrated oligopoly where it is dominant) and construction equipment (a fragmented market where it is sub-scale) — plus a captive finance business. They do not move together, and the blend is anchored by the ag fortress, not the construction also-ran.

Agricultural equipment — a genuine oligopoly, and Deere’s fortress. The large-ag market is an “elephant-and-ants” structure with formidable barriers to entry: dealer-network density, brand, distribution reach, emissions-compliance R&D scale, and now precision-technology integration. In North American large ag, Deere is dominant — roughly 53% of US large tractors, ~60% of US combines, ~45% of North American large ag, and ~25% of global high-horsepower tractors/combines [industry estimates; Deere 10-K]. The named competitors are AGCO (Fendt, Massey Ferguson, Valtra; PTx precision), CNH Industrial (Case IH, New Holland; Raven precision), Kubota (small-ag/compact, low-cost), CLAAS, and Toro (turf). The demand driver is net farm income, which drives farmer capital spending: it has fallen sharply from the 2022 highs as corn and soybean prices retreated, and the down-cycle has been compounded by a glut of used high-horsepower equipment crowding out new-machine sales. This is a structurally good industry — concentrated, high-barrier, with rational pricing behavior even in the downturn (Deere still realized positive price in FY2025–26).

The capital cycle (Marathon lens) — the key constructive structural claim. The single most important industry observation is supply discipline. Unlike the 2014–2016 downturn — which Deere and peers deepened by over-building into falling demand — Deere has this cycle deliberately underproduced retail demand by ~10% in FY2025, draining both field and used inventory. By the end of FY2025, North American 220hp+ tractor field inventory sat at its lowest unit level in 17+ years; used MY22–23 8R tractors were down ~45% from their 2025 peak; and combine/4WD inventory-to-sales ratios fell to ~8%. Management plans to produce in line with retail demand in FY2026 — i.e., the destock phase is ending — and repeatedly flags the aging fleet as the building replacement catalyst. In Marathon terms this is a textbook supply-discipline-into-recovery inflection: capacity restrained, channel cleansed, fleet aging into an eventual replacement wave. This is the strongest structural argument for the stock, and it is verifiable in the inventory data rather than mere narrative.

Construction equipment — fragmented, contested, structurally average-to-poor for Deere. Here Deere is a distant #4–5 globally at roughly 4.9% share, versus Caterpillar ~16.3%, Komatsu ~10.7%, and China’s XCMG ~5.8% — a fragmented market (top-5 ~40%) under pressure from low-cost Chinese OEMs (SANY, XCMG, LiuGong). C&F took the worst FY2025 operating-profit hit (margin collapsing 18.2% → 9.0%) and is the most cyclical, least-advantaged leg. Deere’s Wirtgen roadbuilding franchise (acquired 2017) is a genuine global leader within its niche, and a forthcoming Deere-designed excavator line (mid-2026) addresses ~40% of the earthmoving TAM Deere does not currently serve — but structurally, construction is the weak sister to the ag franchise.

Regulation and cross-cutting factors. Emissions standards (Tier 4 / Stage V) raise compliance and R&D barriers that favor scale incumbents — moat-reinforcing. Right-to-repair is the live regulatory/litigation threat (the FTC and five state AGs sued Deere in January 2025; an antitrust MDL is consolidated in N.D. Illinois) directly targeting the captive-parts service economics. Tariffs are a current, quantified cost headwind — ~$1.2B gross in FY2026 (~3 points of equipment-operations margin), netting to ~$900M after a one-time $272M IEEPA refund — and, more insidiously, a demand headwind, because trade friction (especially China–US soybean dynamics) hits Deere’s farmer-customers’ incomes directly.

Verdict. A barbell: a structurally good agricultural-equipment oligopoly where Deere is dominant and the capital cycle is turning favorable (disciplined supply, cleansed inventory, aging fleet), bolted to a structurally average-to-poor construction business where Deere is sub-scale and Chinese-pressured. The blended industry quality is high — and notably better-managed this cycle than last — but the ag franchise is doing all the heavy lifting.

4. Competitive Position

The moat is real, wide, and financially proven — and, as with Caterpillar, it is primarily a distribution-and-aftermarket moat reinforced by scale, not merely a product moat. In Greenwald’s taxonomy (Competition Demystified), Deere’s advantage is best described as economies of scale reinforced by customer captivity, layered with brand intangibles. Four reinforcing mechanisms:

1. The dealer network + captive aftermarket (demand captivity + switching costs). Deere sells through ~2,050 independent US/Canada dealer locations (~1,600 ag), increasingly consolidated into large, well-capitalized dealer groups that carry proprietary parts, perform service, extend financing, and own the customer relationship and the resale market. As with CAT, the switching cost is not the machine — it is parts availability, the service network, uptime, and resale value, all of which flow through the green-and-yellow channel over a machine’s multi-decade life. This captive aftermarket is the counter-cyclical, high-margin core of the model and the reason returns on capital stay high even in a trough.

2. Precision agriculture + data (switching-cost reinforcement). Deere’s installed base streams data into the Operations Center (500M+ engaged acres, ~440k monthly active digital users, MAUs +33% YoY), and the integrated stack — See & Spray, autonomy, JDLink, Precision Essentials — raises switching costs for tech-integrated farmers. Subscription stickiness is real and improving: Precision Essentials renewal is ~70% overall but >90% for the second-year cohort, a genuine switching-cost signal.

3. Scale (R&D, compliance, distribution). Deere spends the largest R&D budget in agriculture — $2.31B in FY2025, rising to 5.9% of equipment sales even as revenue fell — spread over the largest revenue base in the industry. This is the self-reinforcing Greenwald loop: share → lower unit cost and more R&D → product leadership → share.

4. Brand. “Nothing Runs Like a Deere,” the leaping-deer mark, and green-and-yellow loyalty support a real resale premium and price premium in developed markets — secondary to the structural mechanisms above, but genuine and 10-K-cited as a material protected asset.

Frameworks tests. Market-share-stability test (Greenwald’s primary moat test): Deere has held ~50–60% US large-tractor/combine share for decades with high stability — it passes strongly. ROIC test: through-cycle returns sit far above cost of capital — even in the FY2025 trough, equipment-operations operating return on operating assets (OROA) was ~22%, and the company’s internal shareholder-value-added (SVA) metric was a positive ~$2.4B over a ~12% pre-tax asset cost-of-capital hurdle. A business that clears its cost of capital by a wide margin at the bottom of its worst cycle in a decade has a real, durable advantage. Both tests pass.

Where I am skeptical — the “data moat” is retention, not (yet) its own moat. The precision-ag “data network effect” is asserted constantly, but its financial outcome cannot today be isolated. The clearest evidence: management’s flagship “10% of revenue from recurring sources by 2030” target was removed and pushed past 2030 at the December 2025 Investor Day. Per a disciplined moat standard — if a moat claim can’t be tied to a financial outcome that would deteriorate without it, it isn’t (yet) a standalone moat — the data layer currently functions as a retention/switching-cost enhancer of the iron-plus-parts franchise, not a proven independent profit engine. That distinction matters for valuation: paying for monetized recurring software here is paying for an ambition management itself just delayed.

The bear’s spine — the right-to-repair assault on the parts annuity. Deere faces (a) a consolidated antitrust MDL (N.D. Illinois) alleging monopolization of the repair-services market by restricting repair tools/software/parts to authorized dealers, and (b) an FTC + five-state-AG lawsuit (filed January 2025) on similar claims. Deere booked a $95M pre-tax accrual in Q4 FY2025 and warns resolution “could have a material adverse effect.” This goes straight at the captive-parts mechanism that is the financial core of the moat — the single most important moat risk in the report.

Head-to-head. vs AGCO (PTx precision, Fendt premium) and CNH (Case IH/New Holland, Raven) — credible large-ag competitors, but neither matches Deere’s North American dealer density, share, or R&D scale; both trade at roughly half Deere’s multiple, the market’s verdict on relative quality. vs Kubota — winning small-ag/compact on price, a real share threat at the low end of SAT. vs CAT/Komatsu in construction — Deere is the sub-scale challenger, not the leader.

Verdict. A wide, durable competitive advantage in large North American agriculture — among the best moats in capital goods, passing both Greenwald tests — but contested at the edges: right-to-repair threatens the parts annuity, construction is sub-scale, and the celebrated data moat is real as retention but unproven as standalone monetization. A genuine franchise in a constructive part of its capital cycle, not an unassailable fortress.

5. Growth History and Forward Opportunities

History — a structurally-rising cyclical. Deere’s worldwide net sales and revenues over five years: $44.0B (FY21) → $52.6B (FY22) → $61.3B (FY23, peak) → $51.7B (FY24) → $45.7B (FY25, trough). Management’s own decade framing is the more useful lens: net-sales CAGR of ~7% (2000s) → ~5% (2010s) → ~4% (2020–25, through the volatility), while decade-average equipment-operations operating margin (OROS) rose from ~8% (2000s) → ~12% (2010s) → ~17% (2020–25). The long-run story is genuine: each cycle has been structurally more profitable than the last, driven by the Wirtgen acquisition, global expansion, the Smart Industrial reorganization, and a deliberate mix-shift toward higher-margin precision content.

The “more profitable at the bottom than we used to be at the top” claim — partly true, and verifiable. Deere’s FY2025 trough OROS of 12.6% was >450bps better than the comparable 2016 trough (>600bps ex-tariffs), and FY2025 income and margin exceeded FY2020 despite a lower cycle point. The honest framing is “this trough now roughly equals the prior mid-cycle” — impressive, but not the literal “trough beats prior peak” (the FY2013 peak ran high-teens/20% OROS). The structural-margin gain is real and is the backbone of the bull thesis.

The forward growth story — and the reality check the narrative needs. Management’s December 2025 “Leap Ambition” targets a 10% net-sales CAGR from 2025 to 2030 (→ ~$63B equipment sales, ~$24B of growth), engaged acres of 600M (50% highly engaged), and 1M monthly active digital users. But the composition is the whole point, and it cuts against the “software re-rating” thesis: of the ~$24B of targeted 2030 growth, management attributes only ~$2–3B (~8–12%) to incremental SaaS + Lifecycle Solutions; the remainder is “traditional growth” — cyclical recovery, inflationary price, share gains, and M&A. In other words, the 10% CAGR rests overwhelmingly on the hardware cycle turning, not on a software annuity. And the prior flagship “10% of revenue from recurring sources by 2030” target was explicitly walked back — “the timeline … will extend beyond 2030” — blamed on the soft ag market, the time to build SaaS infrastructure, and slower adoption.

That said, the technology is unambiguously real and adopting: See & Spray acres grew 1M (2024) → 5M+ (2025) with demonstrated 50–60% herbicide savings and 3/4 of 2025 units sold as retrofits (monetizing the installed base, not just new iron); Harvest Settings Automation hit a >90% take rate on North American combines in its first year; JDLink Boost (Starlink) surpassed 12,500 kits. The precision-ag moat is real and deepening as adoption; the recurring revenue is slower and smaller than the headline.

Forward opportunities, ranked. (1) Cyclical large-ag replacement when it inflects (management says 2027) — the largest swing factor; lean field inventory plus a cleaned-up used market sets up sharp operating leverage. (2) C&F secular/share growth — the new excavator line, SmartGrade, and a road-building order book up ~60% since November. (3) Precision-ag/Lifecycle monetization — real but back-end-loaded (~$2–3B by 2030). (4) International — Brazil share gains, India small ag. (5) Aftermarket — the new tiered “John Deere Essentials” parts line (mid-2026) aimed at recapturing mid-life equipment that defects to third-party parts.

Verdict. A high-quality franchise, but the near-term growth on offer is a cyclical hardware recovery, not the high-margin software compounding the narrative implies. The structural trough-margin improvement is verified and impressive. But the two pillars of the bull “re-rating” case — the recurring-software ramp and the 20% mid-cycle margin — have both been pushed past 2030 by management’s own admission. Anyone underwriting DE as a software compounder today is paying for an ambition the company just deferred.

6. Financial Quality

Five-year income statement (equipment operations + consolidated).

[Source: FY2021–FY2025 10-Ks; EDGAR XBRL. FY25 was a 53-week year.]

The defining fact: a ~50% peak-to-trough earnings decline, and the bottom isn’t behind us. Net income fell from $10.17B (FY23) to $5.03B (FY25), with cost-of-sales/net-sales worsening ~360bps (68.8% → 72.4%) on volume deleverage, tariffs, and the inefficiency of deliberately underproducing. Q2 FY2026 (ended ~May 3, 2026) showed the diversification working: net sales $11.78B (+5%), net income $1.77B, EPS $6.55, with SAT (+16%) and C&F (+29%) offsetting PPA (−14%). But that Q2 margin of 16.9% was flattered ~2.5 points by the one-time $272M IEEPA tariff refund (underlying ~14.4%), and FY2026 net income is guided to $4.5–5.0B — a second trough, plausibly below FY25 — compounded by a tax-rate normalization from ~20% to 24–26% (a ~$0.3–0.5B EPS headwind).

Segment margin swing — PPA is the epicenter. Production & Precision Ag operating margin collapsed from 26.1% (FY23) to 15.4% (FY25), operating profit −62%; C&F from 18.2% to 9.0%; SAT from 17.7% to 11.8%. The one counter-cyclical bright spot: Financial Services operating profit rose from $0.80B to $1.11B as credit costs stayed benign — the captive bank is a genuine stabilizer.

Returns on capital — very high, partly buyback-flattered, but a real moat signal. Reported ROE was 48.4% (FY23) → 31.8% (FY24) → 20.6% (FY25). This is inflated by ~$36B of treasury stock that depresses book equity (book value/share ~$96–101, P/B ~5.6–5.9x), so ROE overstates economic returns. The cleaner reads corroborate the moat anyway: equipment-operations OROA of ~22% in a trough year, and positive SVA over a ~12% pre-tax cost-of-capital hurdle. This is a high-quality, high-return industrial business even at the bottom.

Cash flow — strong, but use equipment-operations figures. Consolidated operating cash flow is distorted by finance-receivable timing; the relevant metric is equipment-operations free cash flow: $10.4B (FY23) → $5.3B (FY24) → $3.7B (FY25), with FY2026 equipment-ops operating cash flow guided to $4.5–5.5B. Even at the trough, the equipment business throws off ~$4B of FCF on a ~$155B market cap — a ~2.4% trough FCF yield that would rise toward ~5–6% on mid-cycle cash generation.

Balance sheet — separate the two companies. This is essential and routinely mis-read (yfinance’s $48B “total debt” and $193B EV conflate the two). Equipment operations are fortress-modest: ~$6.3B cash + $0.2B securities against ~$9.2B borrowings → only ~$2.6B net debt (<0.65x trough net income). Financial Services carries ~$54.8B of debt, term-funded and securitized, self-liquidating against a ~$51.4B net financing-receivables book, with ~$7.1B of its own equity. Industrial leverage is conservative and single-A-rated; the large consolidated “total debt” is a captive-finance artifact, not enterprise leverage. Pension/OPEB is overfunded (a net retirement-benefit asset of ~$3.3B — a quality positive). Goodwill is just ~$4.2B (~4% of assets) — a build-not-buy operator with a real book.

Quality-of-earnings flags. FY23’s peak was modestly flattered by a Brazil tax ruling (~$243M); FY24 carried ~$157M of white-collar separation costs; FY25 absorbed a $95M antitrust litigation accrual and a $61M Kreisel battery impairment; Q2 FY26 included the $272M one-time tariff refund. None are large enough to change the picture, but the run-rate should be read ex-these items.

Verdict. High-quality economics that genuinely improve with scale and stay above cost of capital even in a trough — but unmistakably cyclical, with a second trough year ahead and headline ROE flattered by buybacks. Cash conversion is excellent, the (properly-separated) balance sheet is conservative, and the moat shows up in trough-year returns. This is a very good business at the bottom of a deep cycle, not a broken one.

7. Capital Allocation

Track record — strong, with one pro-cyclical blemish. Deere’s capital allocation is, on balance, a genuine strength.

• Dividends. Grown from $3.61/share (FY21) to $6.48 (FY25) — a ~16% CAGR — currently $1.62/quarter, a ~1.14–1.22% yield, and only ~35% of trough EPS. The dividend is conservatively sized and well-covered; it is the floor, not the main lever.
• Buybacks — the dominant lever, but mistimed. Repurchases ran $2.5B (FY21), $3.6B (FY22), $7.2B (FY23), $4.0B (FY24), and $1.1B (FY25) — i.e., Deere bought the most at the FY23 peak (~$450–470/share) and the least in the FY25 trough. That is a textbook buy-high pattern and the clearest capital-allocation criticism: the company returned ~$60B over the past 25 years (~half since 2020) and retired ~13.5% of shares in four years (314M → 271.7M), but the timing transferred value from continuing holders to sellers at the top. ~$7.9B remains on the $18B authorization. The stated policy — return “substantially all” remaining equipment-ops FCF over a cycle while holding a single-A rating — is sound; the execution has been pro-cyclical.
• M&A — disciplined, build-not-buy. Only tiny bolt-ons in the five-year window (Bear Flag Robotics 2021 autonomy; Kreisel batteries, just impaired $61M; SparkAI; Smart Apply). The only large historical deal is Wirtgen (2017, ~$5.2B roadbuilding), outside the window. Goodwill of just ~$4.2B confirms no destructive megadeal — a meaningful positive in an industry that often destroys value through acquisition. Deere sold 50% of Banco John Deere to Bradesco in FY25, deconsolidating it.
• R&D — counter-cyclical commitment. R&D rose every year through the downturn, from $1.59B (FY21) to $2.31B (FY25), climbing from 4.0% to 5.9% of equipment sales — a deliberate investment in precision-ag/autonomy through the trough. Whether this earns its return depends on the deferred monetization — the one place “build-not-buy” discipline meets a not-yet-proven payoff.

Incentive alignment — genuinely good. The proxy (DEF 14A, 2026-01-14) keys the short-term incentive to OROA (50%), OROS (40%), and Financial Services ROE (10%) — returns- and margin-based, not volume-based — and the long-term incentive (now all-equity, cash LTIC eliminated) to relative revenue growth + three-year relative TSR. These are the metrics that restrain empire-building. One caveat: FY25 STI paid 160.8% of target in a trough year (defended by the structural-improvement framing), which sits slightly uneasily against a 50% earnings decline — though, to the plan’s credit, below-threshold relative TSR did cut the final LTIC cycle payout, evidence the equity alignment has teeth.

Insider behavior — a notable absence of conviction. Across the entire Form 4 corpus (195 filings, five years), there was exactly one open-market purchase — a director’s ~$250k token buy in June 2023. CEO John May and CFO Josh Jepsen show only grants, tax-withholding, and option exercise-and-sell — zero discretionary open-market buys, including through the ~30%+ drawdown from the peak. Not a red flag (executives hold large equity stakes via grants), but conspicuously not a conviction signal at what management itself calls the cycle bottom.

Verdict. Management has allocated capital well overall — disciplined M&A, low goodwill, a well-covered growing dividend, counter-cyclical R&D, and a returns-based incentive design — with one real blemish: the buyback was pro-cyclical, spending most at the top and least at the bottom. The absence of insider buying at the claimed trough is a mild negative. On balance, a shareholder-aligned operator, not a capital destroyer.

8. Changes and Headwinds — Last Two Years

The down-cycle and the production-discipline response. The defining change is the ag downturn itself (FY24–26) and, more importantly, how Deere has managed it. Management ran a textbook supply-side playbook — underproducing retail demand ~10%, draining used inventory (MY22–23 8R tractors −45% from peak, 220hp+ field inventory to a 17-year low) — the deliberate opposite of the 2014–16 over-build. This front-loads the pain and sharpens the eventual recovery, and it is the genuine positive of the period.

Cycle position per management — bottoming, on deteriorating assumptions. Management’s base case is that “2026 will represent the bottom of the ag cycle,” with recovery from 2027. But the supporting assumptions have weakened over FY26: the South America guide was cut from −5% to −15% (Brazil weakness, a stronger real, the Iran conflict lifting oil/fertilizer costs), while North American large ag held at −15% to −20%. The “2027 recovery” is a hypothesis with softening support.

Tariffs — cost and demand headwind. FY2026 direct tariff exposure is ~$1.2B (~3 points of equipment-ops margin), netting to ~$900M after the one-time $272M IEEPA refund; split ~45% C&F, ~1/3 SAT, ~20% large ag. Deere is not surcharging customers (price realization ~1.5–2%, roughly matching ex-tariff inflation), so tariffs are margin-dilutive. More insidiously, trade friction hits farmer incomes (China–US soybean trade), depressing the very demand Deere needs to recover. ~80% of US sales are US-built, and Deere has announced a $20B US-manufacturing commitment over ten years — a deliberate counter-narrative to political scrutiny of its Mexico production moves.

Right-to-repair litigation. The FTC and five state AGs sued Deere in January 2025; an antitrust MDL is consolidated in N.D. Illinois. Both target the captive repair/parts economics. A $95M accrual is booked; the 10-K warns of a possible material adverse effect. Conspicuously, management did not address this on any FY25–26 earnings call — a notable omission given its materiality to the moat.

Leadership change. CFO transition — Josh Jepsen (CFO through the December 2025 Investor Day) handed off to Brent Norwood (returning from running C&F) as of the Q2 FY2026 call; John May remains Chairman and CEO. A mid-cycle CFO change into the recovery is a modest execution watch-item, not a thesis-breaker.

The deferred 2030 ambitions. Both the 20% mid-cycle margin target and the 10%-recurring-revenue target were pushed past 2030 — the clearest “change” to the long-term bull narrative, and one driven by tariffs and the soft market rather than execution failure.

Verdict. A mix of genuine strengthening (best-in-class cycle management, lean inventory, structural margin gains) and real risk-adding developments (a second trough year, tariffs as both cost and demand drag, right-to-repair, deferred 2030 targets, a CFO change). On net, the franchise is being managed well through a worsening-at-the-margin macro — and the long-term re-rating story has been quietly pushed to the right.

9. Risk Analysis

Verdict. The dominant risks are not existential — they are (1) a longer-than-priced down-cycle, (2) multiple de-rating from a high own-history starting point, and (3) the right-to-repair threat to the parts annuity. The first two attack the valuation premium; the third attacks the moat itself. None is a candidate for permanent business failure; the realistic downside is a meaningful drawdown from paying a top-of-range multiple at the bottom of an earnings cycle whose recovery keeps slipping.

10. Valuation Discussion (Embedded Expectations)

No price target and no recommendation. This section frames what the current price requires and the scenario range.

Where DE trades — versus peers and versus itself.

[Source: market data, 2026-06-12. KUBTY ADR EV/EBITDA and P/S are data artifacts (n/m). CNH trailing P/E distorted by depressed trailing E.]

The whole debate in one table. DE trades at a ~80% forward-P/E premium to its ag-equipment peers (25.2x vs a ~13.8x median) and roughly double AGCO and Kubota. That premium is the market’s verdict that Deere is the best-in-class franchise — higher share, higher returns, better technology, better cycle management — and it is largely deserved on quality. But its size is the question: at the top of its own ten-year valuation history, the premium leaves no room for the quality to disappoint.

Own-history extreme — the key bear datapoint. On the AZI own-history valuation index, DE sits at the 96th percentile on price-to-sales, 96th on P/E, 74th on P/B, and 89th composite versus its trailing ~10 years. The critical nuance: this is despite trough earnings. A cyclical at a trough normally trades at a high P/E (depressed E) but a low price-to-sales and a cheap absolute price — here, price-to-sales is near its all-time high. The market has already fully normalized Deere’s earnings and is paying a premium multiple on those normalized earnings — there is no “cheap cyclical at the bottom” discount left to capture.

Embedded expectations — the trough-vs-mid-cycle bridge. The reverse-DCF reduces to which earnings anchor you accept:

• On trough EPS (~$18.50 FY25 / FY26 guided similar): ~31x — expensive on its face, but the wrong denominator for a cyclical.
• On management’s mid-cycle EPS (~$40–45): ~13–14x — in line with where ag peers trade on their own normalized earnings, i.e., the quality premium largely evaporates when you give Deere credit for the recovery. On this anchor, DE is reasonable-to-attractive.
• On management’s claimed next-cycle bottom of $20–25 (which management says will exceed this trough): ~23–28x.

So the buyer at ~$569 is paying ~13–14x a mid-cycle that (a) requires the 20% structural margin tariffs just deferred, and (b) requires the 2027+ recovery on assumptions that have softened. The price is defensible if — and only if — you trust management’s normalized-earnings framework and the recovery timing. If mid-cycle EPS proves to be ~$35 rather than ~$42 (margins fall short), the same price is ~16x mid-cycle, and the peer-relative premium widens uncomfortably.

Scenario analysis (directional only — no target).

The asymmetry. Unlike CAT (peak-E × peak-multiple double jeopardy), DE is trough-E × high-own-history-multiple — a milder asymmetry, because the trough earnings protect the downside somewhat (you’re not paying a peak multiple on peak earnings). But the upside is also capped by the starting multiple: even the bull case requires the quality premium to persist at the top of its range. The skew is roughly balanced-to-slightly-unfavorable at ~$569, turning favorable in the ~$450–500 zone where the recovery is no longer fully pre-paid.

Verdict. The market is pricing Deere as a best-in-class cyclical whose earnings will normalize toward management’s mid-cycle framework — and is paying a full, top-of-own-history multiple for that conviction. The franchise quality supports a peer premium; the size of the premium at the bottom of the cycle leaves little margin of safety if the recovery is late or the mid-cycle margin falls short. Fair value, not a bargain.

11. Variant Perception

Consensus. Deere is the blue-chip way to own the eventual ag recovery: the best franchise, best-managed down-cycle (lean inventory, disciplined production), structurally higher trough margins than ever, and an aging fleet that must be replaced. Buy the quality leader at the bottom and wait for 2027. The Street rates it favorably (analyst target ~$645), and the stock’s resilience near the top of its valuation range despite halved earnings validates the “look-through” reflexively.

Strongest bull case. Deere has structurally re-rated its own earnings power — FY25’s trough margin roughly equals the prior mid-cycle, and the next trough should exceed this one. Field and used inventory are at multi-year lows, the fleet is aging, and large-ag replacement is coiled for sharp operating leverage when farm income turns. Precision-ag adoption (See & Spray 5M+ acres, >90% harvest-automation take rates) is deepening switching costs and seeds an eventual high-margin recurring annuity. On ~$40–45 mid-cycle EPS, ~13–14x is cheap for a franchise of this quality, and the dividend-plus-buyback returns the great majority of FCF while you wait.

Strongest bear case. DE is at the top of its own ten-year valuation range (96th-pctile P/S) at the bottom of its earnings cycle — the recovery is fully pre-paid, with no cheap-cyclical discount to harvest. Both pillars of the re-rating thesis — 20% mid-cycle margins and 10%-recurring-revenue — have been pushed past 2030 by management. FY26 is a second trough on softening South American/macro assumptions, so the “2027 recovery” may slip. The parts-and-service annuity that drives the moat’s trough-year returns is under direct legal attack (FTC + AGs + MDL). And the premium to ag peers (~2x AGCO/Kubota/CNH on forward earnings) is large enough that even a successful recovery may be offset by multiple normalization. You are paying for quality at a price that requires the quality to keep over-delivering.

The 3–5 assumptions that matter most. (1) Is 2026 actually the bottom, and does large-ag replacement inflect in 2027? (2) Is mid-cycle EPS really ~$40–45, or closer to ~$35 once tariffs/margin slippage are honest? (3) Does the right-to-repair litigation force open the parts annuity? (4) Does precision-ag ever become a monetized recurring engine, or stay a retention tool? (5) Does the ~80% peer premium persist, or mean-revert?

Falsification. Falsifies the bull: a third deferral of the mid-cycle margin target; large-ag retail demand still falling in FY2027; an adverse right-to-repair ruling; or the multiple de-rating despite a recovering top line (signaling the premium was a regime, not a fixture). Falsifies the bear: a confirmed 2026 bottom with 2027 large-ag inflection, the 20% OROS path resuming, precision-ag recurring revenue visibly ramping, and the peer premium holding through the recovery — which together would prove the market correctly paid up for a structurally-better cyclical.

Positioning. Short interest is only ~2% of float — not a crowded short, and institutions own ~83%. This is a quality-at-a-full-price / patient-accumulation configuration, not a contrarian short and not a deep-value bargain. The variant insight is not “the bull is wrong about the business” — it is “the price has already paid for the recovery, so your return depends on the recovery exceeding an already-normalized expectation, with a real moat-erosion tail risk you’re not being compensated for.”

Verdict. Consensus is directionally right about the franchise and the eventual recovery, and probably a touch too comfortable about the price and the timing. The most useful variant point: a cyclical trading at the top of its own valuation range at the trough has already discounted the good news — the margin of safety lives at lower prices, not here.

12. Fact vs. Interpretation Table

13. Open Questions

1. Is mid-cycle EPS really ~$40–45? The entire valuation rests on this. If post-tariff structural margins settle below 20% OROS, mid-cycle EPS could be ~$35, and the stock is meaningfully dearer than it looks.
2. Is 2026 actually the bottom? South America guidance was cut from −5% to −15% over FY26; the 2027 recovery is a management hypothesis on deteriorating inputs.
3. Right-to-repair outcome. The $95M accrual is likely a floor. A consent decree opening repair tooling/parts to independents would structurally erode the aftermarket annuity — the moat’s trough-year ballast.
4. Precision-ag monetization. Will recurring software ever become an isolable, growing P&L line, or remain a retention tool? Management just deferred the target.
5. Aftermarket-parts economics. Deere does not disclose parts revenue/margin; the captive-parts annuity is the moat’s core but is a black box to outside analysts.
6. Tariff trajectory. ~$1.2B gross FY26 cost is fluid (IEEPA/Section 122/232 churn); any IEEPA refunds beyond the $272M already booked are upside optionality.
7. Will the buyback stay disciplined this cycle, or repeat the FY23 over-buy at the next peak?

14. What Must Be True

For the bull case to work (and its falsification test): Deere must prove that 2026 is the cyclical bottom and that large-agriculture replacement demand inflects upward in 2027 — driving operating leverage off lean field/used inventory — while the structural mid-cycle margin resumes its path toward 20% OROS (delivering ~$40–45 mid-cycle EPS), the parts annuity survives right-to-repair intact, and the market continues to award a best-in-class premium to ag peers. In short: the recovery must come on schedule, the structural margin gains must be real and durable, and the premium multiple must persist. Falsification: large-ag retail demand still declining in FY2027; a third deferral of the 20% margin target; an adverse right-to-repair ruling; or the multiple de-rating toward ag-peer norms despite a recovering top line.

For the bear case to work (and its falsification test): The market must come to see that it has paid a top-of-own-history multiple for a recovery that is late, shallower than hoped, or margin-light — through a slipping recovery, a mid-cycle margin that settles below 18%, a right-to-repair erosion of the parts annuity, or simple multiple mean-reversion toward the ~14x that ag peers command. Falsification: a confirmed 2026 bottom, a 2027 large-ag inflection, the 20% OROS path resuming, visible precision-ag recurring-revenue ramp, and the peer premium holding through the recovery — together proving the market correctly paid up for a structurally-superior cyclical at its trough.

The crux. Both cases hinge on the same facts viewed through opposite lenses: the timing and shape of the ag recovery and the durability of Deere’s structural margin gains and its premium multiple. The bull needs the recovery, the margins, and the premium all to hold; the bear needs any one to crack. At ~$569 — the top of Deere’s own valuation range at the bottom of its earnings cycle — the burden of proof sits with the bull, and the price already assumes much of that burden is met. The margin of safety lives at lower prices.

15. Source Appendix

Primary sources: Deere & Company FY2021–FY2025 Forms 10-K and Q1/Q2 FY2026 Forms 10-Q (SEC EDGAR, CIK 0000315189); 2026 DEF 14A proxy; Form 8-K filings; Form 3/4/5 insider corpus; Deere Q3 FY2025–Q2 FY2026 earnings-call transcripts and the June 2025 and December 2025 Analyst/Investor Days; SEC EDGAR XBRL financial data; yfinance market data and peer comparables (AGCO, CNH, Kubota, Caterpillar, PACCAR); AZI internal fundamentals/valuation-index feeds; a companion Caterpillar analysis; and external industry sources on agricultural-equipment market shares and the ag cycle. Every non-obvious fact is cited inline with source and date in the body above.

This is the author’s independent research and general information, not investment advice. The body of the analysis carries no investment recommendation and no price target; the opening “Claude’s Take” block is a clearly-labeled subjective opinion. Management commentary is treated throughout as hypothesis requiring external validation, not as evidence.

APPENDIX A — Standard Diligence Questionnaire

Deere & Company (NYSE: DE) — Standard Diligence Questionnaire Appendix

Date: 2026-06-12 ·

This appendix answers a standard set of diligence questions. Fact/Interpretation/Assumption labels applied where material. Where a question does not map to Deere’s model, the correct sector analog is given.

General

What thoughtful questions have other investors asked about this company? The sophisticated questions on the FY25–26 calls and the two 2025 Investor Days cluster on: (1) where is the ag-cycle bottom and when does large-ag replacement inflect — the single most-asked question, with analysts probing field vs. used inventory levels and fleet age; (2) is the structural trough-margin improvement real and durable (the “more profitable at the bottom than we used to be at the top” claim) — pressed hardest after the 20% mid-cycle target was deferred; (3) the precision-ag monetization timeline — why the 10%-recurring-revenue target slipped past 2030 and what the per-acre business model actually earns; (4) tariff magnitude and mitigation; and (5) South America trajectory (Brazil margins, currency). Conspicuously absent from analyst questioning: the right-to-repair litigation, which management has not addressed on any call.

Cyclicality & Earnings Nature

Are earnings at a cyclical high or low? Fact/Interpretation: a clear cyclical low. Net income fell ~50% from the FY23 peak ($10.17B) to the FY25 trough ($5.03B), and FY26 is guided to a second trough ($4.5–5.0B). Management states “2026 will represent the bottom of the ag cycle.”

Driven by external environment or internal actions? Predominantly external (falling net farm income, lower corn/soy prices, used-equipment glut, tariffs), but Deere’s internal response — deliberately underproducing retail demand ~10% to drain inventory — has deepened the near-term earnings hit while setting up a sharper recovery. The downturn is the cycle; the trough margin’s resilience is internal (Smart Industrial mix-shift, cost discipline).

How stable are revenues? Cyclical. ~71% of equipment sales (PPA + SAT) track the ag capital-spending cycle; C&F (~29%) tracks construction. The aftermarket-parts annuity and Financial Services (whose profit rose through the downturn) provide counter-cyclical ballast, but headline revenue swung −25% peak-to-trough (NS&R) / −30% (equipment net sales).

Outlook for products/services? Assumption (mgmt): 2026 bottom, 2027 recovery; FY26 PPA −5% to −10%, SAT ~+15%, C&F ~+20%. Long-term 10% net-sales CAGR to 2030 (mostly cyclical/price/share, only ~$2–3B of $24B from SaaS).

How big is the market — growing, shrinking, domestic or international? Large NA ag is a mature, cyclical, high-barrier oligopoly (Deere ~50–60% share) currently shrinking but near trough; small ag/turf and construction are larger, more fragmented, more global. ~52% US sales, with Brazil/Europe/Canada the main international markets.

Business Quality & Competitive Moat

Is the industry getting more or less competitive? Large ag: stable oligopoly (Deere, CNH, AGCO, Kubota, CLAAS) with rational pricing even in the downturn — not meaningfully more competitive, though AGCO/CNH precision-ag offerings contest the tech edge. Small ag: more competitive (Kubota on price). Construction: more competitive (Chinese OEMs), and Deere is sub-scale there.

How profitable is the business (ROIC, ROE)? Fact/Interpretation: very profitable. Reported ROE 20.6% even in the FY25 trough (48.4% at FY23 peak), though buyback-inflated. Cleaner: equipment-operations OROA ~22% at the trough, positive SVA over a ~12% pre-tax cost-of-capital hurdle. Passes the Greenwald high-ROIC test decisively.

How profitable is the industry — competitors, barriers to entry? High barriers (dealer density, brand, emissions R&D scale, precision-tech integration, capital intensity). Deere earns the highest margins in ag; peers AGCO/CNH/Kubota trade at roughly half Deere’s multiple, the market’s relative-quality verdict.

Can the business be easily understood? Yes — it sells tractors, combines, construction iron, parts, and financing. Complexity lives in the captive-finance accounting (separate equipment operations from John Deere Financial) and the precision-ag/recurring-revenue ambitions.

Can it be undermined by foreign low-cost labor? Partially — in small ag/compact (Kubota, Mahindra) and construction (Chinese OEMs). The large-ag fortress is insulated by the dealer/aftermarket network, brand, and emissions-compliant engineering. ~80% of US sales are US-built.

Do brands matter? Strongly — “Nothing Runs Like a Deere,” resale premium, and green-and-yellow loyalty are real and 10-K-cited; brand supports pricing power and resale value, especially in developed markets.

Nature of competition? Product capability, dealer/service coverage, uptime/total-cost-of-ownership, financing, precision-ag/technology, resale value, and — at the low end and in construction — price.

Customers’ switching costs? High in large ag: parts availability, service network, resale value, the multi-decade dealer relationship, and increasingly the integrated Operations Center / precision-ag data ecosystem (Precision Essentials renewal >90% in year two).

Financial Condition & Balance Sheet

Assets not fully recognized on the balance sheet? The dealer network (independent, not owned, but the core franchise asset), the aftermarket-parts annuity, the brand, the precision-ag data/installed base, and the overfunded pension (a net ~$3.3B retirement-benefit asset). Economic value far exceeds the ~$26B book equity.

Off-balance-sheet liabilities? Limited and standard (operating leases, purchase obligations, the right-to-repair litigation as a contingent liability with a $95M accrual). The captive-finance debt (~$54.8B) is on-balance-sheet and matched to the receivables book.

How conservative is the accounting? Reasonably conservative — low goodwill (~$4.2B, build-not-buy), overfunded pension, prompt litigation/impairment accruals (Kreisel $61M, antitrust $95M). Watch the equipment-vs-finance consolidation and the 53-week FY25 when comparing periods.

How CapEx-hungry is the business? Moderate — equipment-ops capex ~$1.4B/yr (~3.5% of sales), plus R&D at $2.31B (5.9% of sales, rising counter-cyclically). Not capital-light, but the dealer model offloads distribution capital to independent dealers.

Capital Allocation & Management

How much FCF does the business generate, how is it used, what is the philosophy? Equipment-ops FCF: $10.4B (FY23) → $5.3B (FY24) → $3.7B (FY25). Philosophy: return “substantially all” remaining equipment-ops FCF over a cycle (~$60B over 25 years) via dividends + buybacks, holding a single-A rating. ~$7.9B remains on the $18B buyback authorization.

Significant acquisitions recently? No — only tiny bolt-ons (Bear Flag Robotics, Kreisel, SparkAI) in the five-year window; the last large deal was Wirtgen (2017, ~$5.2B). Goodwill of just ~$4.2B confirms acquisition discipline.

Buying back shares? Yes, aggressively but pro-cyclically — $7.2B at the FY23 peak vs $1.1B in the FY25 trough; shares down ~13.5% in four years (314M → 271.7M). The buy-high timing is the main capital-allocation criticism.

Issuing large amounts of new shares to insiders? No — share count is falling; SBC is immaterial to the model. Insiders own ~0.16%.

Compensation policy of directors/management? STI keyed to OROA (50%) / OROS (40%) / FS ROE (10%); LTI (all-equity) to relative revenue growth + 3-year relative TSR. Returns-and-margin-based, anti-empire-building. Caveat: FY25 STI paid 160.8% of target in a trough, though below-threshold relative TSR cut the LTIC payout (alignment has teeth).

Motivations of management? Interpretation: shareholder-aligned on the metrics, but the absence of any insider open-market buying (1 token purchase in 5 years across all executives/directors, including through a 30%+ drawdown) is a conspicuous non-signal at the claimed cycle bottom.

Valuation & Market Data

Is the stock an ADR, MLP, or K-1 issuer? No — a US domestic C-corp (NYSE: DE), standard 1099 treatment.

Dividend policy? $1.62/quarter ($6.48 annualized), ~1.14–1.22% yield, ~35% of trough EPS; grown ~16% CAGR over five years. Conservative and well-covered — the floor of capital return.

How profitable is the business? Very — see ROE/OROA above; among the most profitable franchises in capital goods even at the trough.

Is net income diverging from cash from operations? Consolidated OCF is distorted by finance-receivable timing — use equipment-ops cash flow, which tracks net income reasonably (eq-ops FCF $3.7B vs eq-ops net income $4.1B in FY25). No adverse divergence.

Risks & Downside

What factors would cause the stock to decline? A prolonged/deeper ag down-cycle (no 2027 recovery); multiple de-rating from the 89th-percentile own-history starting point; an adverse right-to-repair outcome eroding the parts annuity; a third deferral of the mid-cycle margin target; worsening tariffs (cost + farmer-income demand hit); South American weakness.

Risk of a catastrophic loss? Low at the business level — diversified, single-A, conservatively levered (industrial), overfunded pension, dominant franchise. The realistic risk is a drawdown from paying a top-of-range multiple at the cycle bottom, not a permanent business impairment.

Chance of a total loss? Negligible. Deere is a 188-year-old, investment-grade, cash-generative global leader; total loss would require a multi-decade competitive and financial collapse with no precedent.

Recent News & Events

Has the business environment changed recently? Yes — the ag down-cycle deepened (FY26 a second trough), South America guidance was cut from −5% to −15%, and tariffs emerged as a ~$1.2B cost and a farmer-income demand drag. Offsetting: field/used inventory cleaned to multi-year lows, setting up the eventual recovery.

Significant acquisitions? No recent material M&A (bolt-ons only); sold 50% of Banco John Deere to Bradesco in FY25.

Change in accounting policies? None material; FY25 was a 53-week year (a comparability note, not a policy change).

Recent changes — new markets, facilities, management? New Deere-designed excavator line (mid-2026); tiered “John Deere Essentials” aftermarket parts line (mid-2026); $20B US-manufacturing commitment over ten years; CFO transition (Josh Jepsen → Brent Norwood, Q2 FY2026); both 2030 flagship targets (20% margin, 10%-recurring-revenue) deferred past 2030.

APPENDIX B — Source Appendix

Deere & Company (NYSE: DE) — Source Appendix

Date: 2026-06-12

All non-obvious facts in the memo are cited inline with source and date. This appendix consolidates the source base. Primary sources (SEC filings, company transcripts, regulatory documents) are prioritized over secondary; management commentary is treated as hypothesis requiring external validation .

Primary — SEC Filings (EDGAR, CIK 0000315189)

Reviewed 5-year corpus (5× 10-K, 15× 10-Q, 58× 8-K, 5× DEF 14A, 195× Form 4, 11× Form 3, plus 11-K/ARS/S-3ASR/SD).

• Form 10-K, FY2025 (period ended 2025-11-02; filed 2025-12-18) — segment data, income statement, balance sheet, cash flow, supplemental consolidating data (equipment ops vs Financial Services), legal proceedings (right-to-repair MDL + FTC/AG suit, $95M accrual), pension status, R&D, geographic mix, share repurchases. https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000315189
• Forms 10-K, FY2021–FY2024 — five-year income statement, segment margins, buyback/dividend history, share count.
• Form 10-Q, Q2 FY2026 (period ended ~2026-05-03; filed ~2026-05-28) — Q2 results, $272M one-time IEEPA tariff refund, segment detail, FY26 guidance context.
• Form 10-Q, Q1 FY2026 (period ended ~2026-02-01; filed ~2026-02).
• DEF 14A proxy (filed 2026-01-14) — STI metrics (OROA 50% / OROS 40% / FS ROE 10%), LTI design (relative revenue growth + 3-yr relative TSR), FY25 STI payout 160.8% of target, SVA hurdle, CEO/NEO compensation.
• Form 4 corpus (195 filings, 2021–2026) — insider-transaction read: one open-market purchase (director, ~$250k, 2023-06-06); CEO May / CFO Jepsen show only grants/withholding/exercise-and-sell.
• Form 8-K filings — $18B buyback authorization, FY24 employee-separation programs, Banco John Deere/Bradesco JV, earnings releases, leadership changes.

Primary — Earnings-Call & Investor-Day Transcripts

Public company earnings-call and investor-day transcripts.

• Q2 FY2026 earnings call (2026-05-21) — current outlook, 2026-bottom/2027-recovery framing, FY26 guidance ($4.5–5.0B NI; PPA −5/−10%, SAT +15%, C&F +20%; tax 24–26%), tariff detail (~$1.2B, $272M refund), South America cut to −15%, CFO Norwood.
• Q1 FY2026 earnings call (2026-02-19).
• Analyst/Investor Day (2025-12-08) — “Leap Ambition” 2030 targets (10% net-sales CAGR, 600M engaged acres, 1M digital users); normalized EPS framework (mid ~$40–45 / bottom ~$20–25 / top ~$55–60); deferral of the 10%-recurring-revenue target and the 20% mid-cycle margin target past 2030; decade margin/CAGR history.
• Q4 FY2025 earnings call (2025-11-26) — FY25 wrap, inventory destock metrics, structural-margin claim.
• Analyst/Investor Day (2025-06-10), Q3 FY2025 call (2025-08-14), Q2 FY2025 call (2025-05-15), and prior-year calls for trajectory; 2022 Investor Day for prior margin-target progression (12.5% → 15% → 20% OROS).

Primary — Regulatory / Litigation

• FTC + five-state-AG complaint (filed January 2025) — monopolization of repair-services market for Deere equipment.
• Antitrust MDL (In re Deere & Co. Repair Services Antitrust Litigation, N.D. Illinois) — consolidated class action on repair restrictions.

Quantitative Data Helpers

• SEC EDGAR XBRL — net income, segment data reconciliation (note: standard revenue tag empty; Deere reports “Total net sales and revenues” / equipment “Net sales”).
• Own-history valuation percentiles — Deere’s current P/E, P/S, and P/B versus its own trailing ~10-year range (P/E ~96th, P/S ~96th, P/B ~74th, composite ~89th percentile), reconciled to filings.
• Market data / peer comparables — price ($568.64 / ~$576 live), market cap ~$155B, shares ~270M, 52-wk range $433–674; peer comps (AGCO, CNH, Kubota/KUBTY, Caterpillar, PACCAR). EV/total-debt distorted by captive finance — equipment-ops figures used instead.

Internal Prior Work

• output/CAT_2026-06-09_full_report.md — prior Caterpillar analysis informing industry/dealer-moat framing, the machinery competitive set, and DE peer-comparison context (Deere characterized there as the ag-down-cycle peer with a dealer + precision-ag moat).

Secondary — Industry / Market Data

• Agricultural-equipment market-share estimates (Deere ~50–60% US large tractors/combines, ~25% global high-hp; AGCO/CNH/Kubota/CLAAS competitive set).
• Construction-equipment global share data (Deere ~4.9%; CAT ~16.3%, Komatsu ~10.7%, XCMG ~5.8%) — per published industry sources.
• US net-farm-income and corn/soybean price context (USDA-type data) underpinning the ag-cycle framing.

Where management commentary is cited, it is labeled as guidance/hypothesis, not established fact.